Pharmaceutical Outsourcing Services Market, By Service (Product design, Product testing, Consulting, Auditing and Assessment, Regulatory Affairs, Product maintenance, and Training), and Geography (NA, EU, APAC, and RoW) Analysis, Share, Trends, Size, & Forecast From 2014 2025
REPORT HIGHLIGHT
The pharmaceutical/biotechnology services outsourcing market is estimated to represent a global market of USD 43.8 billion by 2017 with growth rate of 7.8%.
Market Dynamics
Driving factors such as increasing approval of new therapeutics coupled with strategic mergers & acquisitions of key players to expand their presence in pharma & biotech industries are expected to remain on the top spot for the growth of pharmaceutical outsourcing services industry globally. For example, in December 2017, as per the article published by the Regulatory Affairs Professional Society, the number of new molecular entity published by the U.S. FDA (around 46) in 2017, was the highest compared to the new drugs approved till 2016.
On contrary, the drug development cost is increasing at a significant rate. According to the estimates of Pharmaceutical Research and Manufacturers of America (PhRMA), the total drug development related R&D spending in 2014 amounted to USD 51.2 billion. Thus, outsourcing process helps a company to save hefty amount, which is spent on R&D; hence, increasing demand for consulting services. On the flip side, raising issues on data security and growing concerns over third-party performance restrain the industry growth to some extent.
Service Takeaway
Service segment is bifurcated into Product design, Product testing, Consulting, Auditing and Assessment, Regulatory Affairs, Product maintenance, Training, and others. Of these, consulting service holds the highest share throughout the study period. In 2017, this segment has captured around 18.5% share and is likely to show robust growth during the forecast period. Consulting services such as remediation, quality management systems, and regulatory compliances are covered under this segment. On another side, regulatory affairs outsourcing is considered to grow with the highest growth rate over the forecast period. Associated benefits such as cost-effectiveness, reduce documentation, and pro-active risk management helps this segment to capture significant revenue share during the future period.
Regional Takeaway
Regionally, developed regions such as North America and Europe accounted for the highest share. In 2017, these regions have captured over 75% revenue share collectively. However, Asia Pacific region is anticipated to show double-digit growth rates (11.2% from 2017-2025) in during the future period. This region is considered to grow with the highest CAGR as it is well positioned to become a preferred destination for pharmaceutical studies. Furthermore, factors such as speedy recruitment, large patient pool, cost-effectiveness, and presence of high-quality infrastructure support the regional growth over the forecast period.
Key Vendor Takeaway
Companies such as Quantic Group, Parexel International, Lachman Associates, Concept Heidelberg, and GMP Pharmaceuticals are profiled in detail. Bolstered by a revival in the pharmaceutical industry, market profit of these players is expected to increase at a significant rate over the future period. Since the industry is fragmented in nature, with no one player accounting for significant revenue share, service-based competition is very high.
Key players are actively engaged in accelerating their pace of change by reducing service cost, focusing on core-competency, and reducing documentary burden. For instance, in July 2016, Quality context Ltd. collaborated with Clarity Compliance Solutions to offer computer system validation services to assure a specific process will consistently produce a product that meets quality attributes and predetermined specifications.
The market size and forecast for each segment and sub-segments has been considered as below:
- Historical Year – 2014 & 2016
- Base Year – 2017
- Estimated Year – 2018
- Projected Year – 2025
TARGET AUDIENCE
- Traders, Distributors, and Suppliers
- Manufacturers
- Hospitals
- Government and Regional Agencies and Research Organizations
- Consultants
- Distributors
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
MARKET, BY SERVICE
- Product Design
- Product Testing
- Consulting
- Auditing and Assessment
- Regulatory Affairs
- Product Maintenance
- Training
- Others
MARKET, BY REGION
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- Rest of Europe
- Asia Pacific
- India
- China
- Rest of APAC
- Rest of the World
- Middle East and Africa
- Latin America
TABLE OF CONTENT
1. PHARMACEUTICAL OUTSOURCING SERVICES MARKET OVERVIEW
1.1. Study Scope
1.2. Assumption and Methodology
2. EXECUTIVE SUMMARY
2.1. Key Market Facts
2.2. Geographical Scenario
2.3. Companies in the Market
3. PHARMACEUTICAL OUTSOURCING SERVICES KEY MARKET TRENDS
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. PHARMACEUTICAL OUTSOURCING SERVICES INDUSTRY STUDY
4.1. Porter’s Analysis
4.2. Market Attractiveness Analysis
4.3. Regulatory Framework Analysis
5. PHARMACEUTICAL OUTSOURCING SERVICES MARKET LANDSCAPE
5.1. Market Share Analysis
6. PHARMACEUTICAL OUTSOURCING SERVICES MARKET – BY SERVICE
6.1. Overview
6.2. Product Design
6.2.1. Overview
6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
6.3. Product Testing
6.3.1. Overview
6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
6.4. Consulting
6.4.1. Overview
6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
6.5. Auditing and Assessment
6.5.1. Overview
6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
6.6. Regulatory Affairs
6.6.1. Overview
6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
6.7. Product Maintenance
6.7.1. Overview
6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
6.8. Training
6.8.1. Overview
6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
6.9. Others
6.9.1. Overview
6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7. PHARMACEUTICAL OUTSOURCING SERVICES MARKET– BY GEOGRAPHY
7.1. Introduction
7.2. North America
7.2.1. Overview
7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7.2.3. U.S.
7.2.3.1. Overview
7.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7.2.4. Canada
7.2.4.1. Overview
7.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7.3. Europe
7.3.1. Overview
7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7.3.3. France
7.3.3.1. Overview
7.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7.3.4. Germany
7.3.4.1. Overview
7.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7.3.5. Rest of Europe
7.3.5.1. Overview
7.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7.4. Asia Pacific (APAC)
7.4.1. Overview
7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7.4.3. China
7.4.3.1. Overview
7.4.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7.4.4. India
7.4.4.1. Overview
7.4.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7.4.5. Rest of APAC
7.4.5.1. Overview
7.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7.5. Rest of the World
7.5.1. Overview
7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7.5.3. Latin America
7.5.3.1. Overview
7.5.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7.5.4. Middle East and Africa
7.5.4.1. Overview
7.5.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8. KEY VENDOR ANALYSIS
8.1. Quantic Group
8.1.1. Company Overview
8.1.2. SWOT Analysis
8.1.3. Key Developments
8.2. Parexel International
8.2.1. Company Overview
8.2.2. SWOT Analysis
8.2.3. Key Developments
8.3. Lachman Associates
8.3.1. Company Overview
8.3.2. SWOT Analysis
8.3.3. Key Developments
8.4. Concept Heidelberg
8.4.1. Company Overview
8.4.2. SWOT Analysis
8.4.3. Key Developments
8.5. GMP Pharmaceuticals
8.5.1. Company Overview
8.5.2. SWOT Analysis
8.5.3. Key Developments
*Client can request additional company profiling as per specific requirements
9. 360 DEGREE ANALYSTVIEW
10. APPENDIX
10.1. Research Methodology
10.2. Abbreviations
10.3. Disclaimer
10.4. Contact Us
List of Tables
Table 1 List of Acronyms
Table 2 Key Market Facts, 2014 – 2025
Table 3 Market Drivers: Impact Analysis
Table 4 Market Restraint: Impact Analysis
Table 5 Market Opportunity: Impact Analysis
Table 6 PEST Analysis
Table 7 Porter’s Five Forces Analysis
Table 8 Company Market Share Analysis
Table 9 Global Pharmaceutical Outsourcing Services Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
Table 10 Pharmaceutical Outsourcing Services Market, by Service, 2014 – 2025 (USD Billion)
Table 11 Pharmaceutical Outsourcing Services Market, by Geography, 2014 – 2025 (USD Billion)
Table 12 North America Pharmaceutical Outsourcing Services Market, 2014 – 2025 (USD Billion)
Table 13 U.S. Pharmaceutical Outsourcing Services Market, 2014 – 2025 (USD Billion)
Table 14 Canada Pharmaceutical Outsourcing Services Market, 2014 – 2025 (USD Billion)
Table 15 Europe Pharmaceutical Outsourcing Services Market, 2014 – 2025 (USD Billion)
Table 16 France Pharmaceutical Outsourcing Services Market, 2014 – 2025 (USD Billion)
Table 17 Germany Pharmaceutical Outsourcing Services Market, 2014 – 2025 (USD Billion)
Table 18 Asia Pacific Pharmaceutical Outsourcing Services Market, 2014 – 2025 (USD Billion)
Table 19 China Pharmaceutical Outsourcing Services Market, 2014 – 2025 (USD Billion)
Table 20 India Pharmaceutical Outsourcing Services Market, 2014 – 2025 (USD Billion)
Table 21 Latin America Pharmaceutical Outsourcing Services Market, 2014 – 2025 (USD Billion)
Table 22 MEA Pharmaceutical Outsourcing Services Market, 2014 – 2025 (USD Billion)
List of Figures
Figure 1 Research Methodology
Figure 2 Research Process Flow Chart
Figure 3 Comparative Analysis, by Geography, 2016-2025 (Value %)
Figure 4 Regulatory Framework Analysis
Figure 5 Pharmaceutical Outsourcing Services Market, by Service, 2014 – 2025 (USD Billion)
Figure 6 Pharmaceutical Outsourcing Services Market, by Geography, 2014 – 2025 (USD Billion)
